A Study to Test a Potential New Treatment for COPD Patients Suffering From the Common Cold or Influenza

Summary

The aim of the study is to assess the safety of inhaled SNG001 and the ability of inhaled SNG001 to 'switch on' the cells' anti-viral defences in patients with chronic obstructive pulmonary disease (COPD). The study consist of two parts. Part 1 will assess the safety of inhaled SNG001 in ten patients with stable COPD. Part 2 will assess efficacy and safety of inhaled SNG001 in 120 patients with COPD with a cold or COPD exacerbation.

Timeline

Start

2018-01-29

Primary completion

2020-05-05

Completion

2020-05-05

Drugs

Indications